Journal of Drug Research in Ayurvedic Sciences

Register      Login

VOLUME 4 , ISSUE 1 ( January–March, 2019 ) > List of Articles

RESEARCH ARTICLE

Subacute Oral Toxicity Assessment of a Herbomineral Formulation with Shilajit, Swarna Bhasma and other Ingredients

Arun Gupta, Satyendra Kumar, Promila Singh, Pankaj Gupta, JLN Sastry

Keywords : Herbometallic, Herbomineral, Organization for Economic Cooperation and Development guidelines, Repeated dose 28-day oral toxicity, Shilajit, Subacute oral toxicity, Swarna bhasma,Ayurveda

Citation Information : Gupta A, Kumar S, Singh P, Gupta P, Sastry J. Subacute Oral Toxicity Assessment of a Herbomineral Formulation with Shilajit, Swarna Bhasma and other Ingredients. J Drug Res Ayurvedic Sci 2019; 4 (1):8-21.

DOI: 10.5005/jdras-10059-0070

License: CC BY-NC 4.0

Published Online: 00-03-2019

Copyright Statement:  Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background: An Ayurvedic herbomineral formulation containing Shilajit, Swarna bhasma, and other ingredients intended to be used as a rejuvenator for increasing strength stamina and endurance was investigated for its subacute oral toxicity in Wistar rats. Materials and methods: The study was conducted as per the Organization for Economic Cooperation and Development (OECD) guidelines. Test item (TI) was administered to three groups at three dose levels (250, 500, and 1000 mg/kg body weight BW) for 28 consecutive days. Animals in one group were taken as high-dose satellite reversal along with one control group and one satellite control group that received Milli-Q water (10 mL/kg BW). Any clinical sign of toxicity/mortality was observed. Signs of delayed onset of toxicity was observed in satellite groups for the next 14 days. Results: No mortality or clinical sign of toxicity was observed. All animals from the treated and satellite groups showed similar weight gain and feeding as of control group during dosing and recovery periods. Hematological and biochemical parameters were within the range of normalcy in treated and control groups. Necropsy examination did not reveal any significant gross pathology changes. Organ weights in treated group were comparable to control group. Histopathology of high-dose-treated animals and control animals was also comparable. Conclusion: Tested formulation containing Shilajit, Swarna bhasma, and other ingredients was found to be nontoxic at tested doses in both the sexes of Wistar rats on subacute administration. Results of the current study show that TI has no observed adverse effect level (NOAEL) of 1000 mg/kg BW on subacute oral exposure to Wistar rats for 28 days.


PDF Share
  1. Carrasco-Gallardo C, Guzmán L, Maccioni RB. Shilajit: a natural phytocomplex with potential procognitive activity. Int J Alzheimers Dis 2012;2012:674142. DOI: 10.1155/2012/674142.
  2. Samhita C, Sastry K, ed. Chaukhambha Subharti Prakashan. Varanasi.
  3. Chopra RN, Chopra IC, Handa KL, et al. Indigenous Drugs of India. Calcutta, India: U.N. Dhar & Sons; 1958.
  4. Chunekar KC, Pandey GS. Bhavamishra: Bhavaprakash Nighantu. Varanasi: Chaukhambha Bharati Academy; 2010. Guduchyadi varga. p. 356.
  5. Chunekar KC, Pandey GS. Bhavamishra: Bhavaprakash Nighantu. Varanasi: Chaukhambha Bharati Academy; 2010. Dhatwadi varga. p. 612.
  6. Chunekar KC, Pandey GS. Bhavamishra: Bhavaprakash Nighantu. Varanasi: Chaukhambha Bharati Academy; 2010. Guduchyadi varga. p. 391.
  7. Chunekar KC, Pandey GS. Bhavamishra: Bhavaprakash Nighantu. Varanasi: Chaukhambha Bharati Academy; 2010. Guduchyadi varga. p. 393.
  8. The Ayurvedic Pharmacopeia of India – Part I. Vol. II. New Delhi: Ministry of Health and Family Welfare, Government of India; 2001; p. 1.
  9. Chunekar KC, Pandey GS. Bhavamishra: Bhavaprakash Nighantu. Varanasi: Chaukhambha Bharati Academy; 2010. Karpooradi varga. p. 216.
  10. Chunekar KC, Pandey GS. Bhavamishra: Bhavaprakash Nighantu. Varanasi: Chaukhambha Bharati Academy; 2010. Karpooradi varga p. 219.
  11. Chunekar KC, Pandey GS. Bhavamishra: Bhavaprakash Nighantu. Varanasi: Chaukhambha Bharati Academy; 2010. Guduchyadi varga. p. 292.
  12. Chunekar KC, Pandey GS. Bhavamishra: Bhavaprakash Nighantu. Varanasi: Chaukhambha Bharati Academy; 2010. Karpooradi varga. p. 233.
  13. Chunekar KC, Pandey GS. Bhavamishra: Bhavaprakash Nighantu. Varanasi: Chaukhambha Bharati Academy; 2010. Karpooradi varga. p. 226.
  14. Chunekar KC, Pandey GS. Bhavamishra: Bhavaprakash Nighantu. Varanasi: Chaukhambha Bharati Academy; 2010. Guduchyadi varga. pp. 386–387.
  15. Chunekar KC, Pandey GS. Bhavamishra: Bhavaprakash Nighantu. Varanasi: Chaukhambha Bharati Academy; 2010. Guduchyadi varga. pp. 387–388.
  16. Sastry KN, Rasatarangini. Motilal Banarsidas. New Delhi Chapter 16/46-51.
  17. Sastry KN, Rasatarangini. Motilal Banarsidas. New Delhi. Chapter 15/69.
  18. Sastry KN, Rasatarangini. Motilal Banarsidas. New Delhi. Chapter-19/120-123.
  19. Chunekar KC, Pandey GS. Bhavamishra: Bhavaprakash Nighantu. Varanasi: Chaukhambha Bharati Academy; 2010. Karpooradi varga. p. 175.
  20. OECD (Organization for Economic Cooperation and Development). Guidelines for Testing of Chemicals. No 407: Repeated Dose 28-Day Oral Toxicity Study in Rodents; Paris, France, July 27, 1995. Available at: https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecdtg407-2008.pdf.
  21. Tatke PA, Nidhiya ISR, Deshpande SG. Safety Profile of a Polyherbal Formulation (Gynocare capsules) in Female Rats by Subchronic Oral Toxicity Study. Toxicol Int. 2012;19(2):106–111. DOI: 10.4103/0971-6580.97196.
  22. Olson H, Betton G, Robinson D, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 2000;32(1):56–67. DOI: 10.1006/rtph.2000.1399.
PDF Share